Amikacin Sulfate
NDC 67184-0569, Amikacin Sulfate, injection, solution, from Qilu Pharmaceutical Co., Ltd..
- Product NDC
- 67184-0569
- Status
- Listed
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218146
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0569 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AMIKACIN SULFATE250 mg/mL
Pharmacologic classes
Aminoglycoside Antibacterial [EPC]; Aminoglycosides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67184-0569-2 | 67184056902 | 10 VIAL, GLASS in 1 CARTON (67184-0569-2) / 2 mL in 1 VIAL, GLASS (67184-0569-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/20fa61ef-11e2-4d01-82ea-b5412cefaead
Use it
Look up 67184-0569 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0569 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67184-0569. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.